Key Laboratory of Preclinical Study for New Drugs of Gansu Province,School of Basic Medical Sciences,Institute of Biochemistry and Molecular Biology and State Key Laboratory of Applied Organic Chemistry,Lanzhou University,222 Tian Shui South Road,Lanzhou,730000,China;
Key Laboratory of Preclinical Study for New Drugs of Gansu Province,School of Basic Medical Sciences,Institute of Biochemistry and Molecular Biology and State Key Laboratory of Applied Organic Chemistry,Lanzhou University,222 Tian Shui South Road,Lanzhou,730000,China;
Key Laboratory of Preclinical Study for New Drugs of Gansu Province,School of Basic Medical Sciences,Institute of Biochemistry and Molecular Biology and State Key Laboratory of Applied Organic Chemistry,Lanzhou University,222 Tian Shui South Road,Lanzhou,730000,Ch;
机译:具有硫酰胺键取代作用的抗菌肽Polybia-MPI的新型类似物,对癌症的治疗效果增强,小鼠毒性降低。
机译:通过提高对多药抗性细菌的安全性和活性提高小鼠中抗菌肽的治疗指数
机译:通过SPOT合成鉴定对多药耐药细菌具有治疗潜力的新型抗菌肽
机译:抗微生物肽可以是治疗多药抗癌和细菌的理想候选者:简单地介绍了一种新型抗微生物肽Polybia-MPI的治疗效果
机译:糖聚合物的水筏聚合用于肽相互作用研究,而抗微生物肽模拟物用于抗微生物活性和选择性研究
机译:通过增加对多药耐药细菌的安全性和活性来增强小鼠抗菌肽的治疗指数
机译:具有硫酰胺键取代作用的抗菌肽Polybia-MPI的新型类似物显示出增强的抗癌治疗功效和小鼠毒性降低